
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp has demonstrated a robust revenue growth trajectory, achieving a compound annual growth rate (CAGR) of 16% since 2022, bolstered by substantial increases in provider solutions and patient payment solutions revenue, which rose by 17% and 27% year-over-year, respectively, in 2024. The company's strategic focus on expanding its presence in the ambulatory sector has led to a notable increase in market share, with an 8% penetration rate compared to a 4% share within hospital and health systems. Additionally, the growth in high-value clients, which increased by 3.4% quarter-over-quarter and now comprises approximately 4.15% of total clientele, further reinforces the company's strong position within the healthcare technology market.
Bears say
Waystar Holding Corp is facing a negative outlook primarily due to decreasing revenue expectations, with sequential declines anticipated in the third quarter and flat performance projected for the fourth quarter. Additionally, the company's EBITDA has significantly decreased from 6.4x at the end of 2023 to 2.2x at the close of the second quarter, indicating deteriorating profitability. Compounding these issues, potential cybersecurity breaches present a risk not only to client confidence but also to Waystar's ability to retain and grow its client base, further jeopardizing its financial stability.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares